In contrast to the previously discussed inhibitory effects of lactate, IDH-mutant gliomas exhibit another form of metabolite-mediated immunosuppression: Their oncometabolite, D-2HG, not only impacts the tumor itself but also modulates immune cell function through tumor-non-autonomous mechanisms. The gene discussed is IDH1; the disease is central nervous system cancer.